| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.809 | 0.001 | 0.809 | CF transmembrane conductance regulator agonist | 0.618 0.002 DBMET02318 0.656 0.002 DBMET02319 | ||
| 0.493 | 0.037 | 0.493 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.39 0.11 DBMET02318 0.384 0.116 DBMET02319 | ||
| 0.447 | 0.052 | 0.447 | Calcium channel L-type activator | 0.408 0.076 DBMET02318 0.42 0.068 DBMET02319 | ||
| 0.425 | 0.051 | 0.425 | GABA C receptor rho-3 antagonist | 0.241 0.162 DBMET02318 0.287 0.125 DBMET02319 | ||
| 0.377 | 0.034 | 0.534 | Interleukin antagonist | 0.223 0.073 DBMET02318 0.534 0.017 DBMET02319 | DBMET02319 | |
| 0.395 | 0.078 | 0.395 | Histamine release inhibitor | 0.229 0.173 DBMET02318 0.368 0.091 DBMET02319 | ||
| 0.346 | 0.035 | 0.346 | Pyruvate kinase inhibitor | 0.164 0.104 DBMET02318 0.258 0.059 DBMET02319 | ||
| 0.354 | 0.047 | 0.354 | Aryl hydrocarbon receptor agonist | 0.147 0.138 DBMET02318 0.187 0.109 DBMET02319 | ||
| 0.39 | 0.084 | 0.39 | 5 Hydroxytryptamine release inhibitor | 0.298 0.167 DBMET02318 0.35 0.115 DBMET02319 | ||
| 0.307 | 0.018 | 0.307 | Lipid peroxidase inhibitor | 0.15 0.068 DBMET02318 0.254 0.026 DBMET02319 | ||
| 0.417 | 0.129 | 0.564 | Antiinflammatory | 0.532 0.075 DBMET02318 0.564 0.064 DBMET02319 | DBMET02319 | |
| 0.326 | 0.053 | 0.326 | Antioxidant | 0.224 0.099 DBMET02318 0.289 0.066 DBMET02319 | ||
| 0.353 | 0.097 | 0.353 | 15-Lipoxygenase inhibitor | |||
| 0.23 | 0.01 | 0.23 | Beta glucuronidase inhibitor | 0.144 0.028 DBMET02318 0.146 0.027 DBMET02319 | ||
| 0.305 | 0.09 | 0.305 | Angiogenesis inhibitor | 0.215 0.153 DBMET02318 | ||
| 0.26 | 0.065 | 0.26 | Free radical scavenger | 0.186 0.109 DBMET02318 0.221 0.082 DBMET02319 | ||
| 0.243 | 0.055 | 0.243 | ErbB-1 antagonist | 0.184 0.109 DBMET02319 | ||
| 0.271 | 0.086 | 0.313 | Lipoxygenase inhibitor | 0.313 0.065 DBMET02319 | DBMET02319 | |
| 0.198 | 0.022 | 0.198 | Farnesoid X receptor antagonist | 0.154 0.048 DBMET02318 0.179 0.03 DBMET02319 | ||
| 0.202 | 0.033 | 0.224 | Cyclooxygenase 1 inhibitor | 0.224 0.026 DBMET02319 | DBMET02319 | |
| 0.233 | 0.076 | 0.353 | Hypolipemic | 0.164 0.123 DBMET02318 0.353 0.035 DBMET02319 | DBMET02319 | |
| 0.167 | 0.011 | 0.167 | Macrophage colony-stimulating factor 1 receptor antagonist | 0.136 0.018 DBMET02318 0.141 0.016 DBMET02319 | ||
| 0.309 | 0.157 | 0.309 | DNA directed DNA polymerase inhibitor | |||
| 0.16 | 0.01 | 0.16 | Interleukin 12 antagonist | 0.134 0.019 DBMET02318 0.146 0.014 DBMET02319 | ||
| 0.213 | 0.069 | 0.213 | Nitric-oxide synthase stimulant | 0.167 0.16 DBMET02318 0.17 0.154 DBMET02319 | ||
| 0.187 | 0.044 | 0.223 | Hexokinase inhibitor | 0.223 0.024 DBMET02318 0.147 0.082 DBMET02319 | DBMET02318 | |
| 0.313 | 0.18 | 0.313 | Caspase 9 stimulant | |||
| 0.238 | 0.111 | 0.238 | Streptokinase A inhibitor | 0.167 0.157 DBMET02318 | ||
| 0.158 | 0.032 | 0.23 | GABA receptor agonist | 0.23 0.012 DBMET02318 0.103 0.073 DBMET02319 | DBMET02318 | |
| 0.252 | 0.126 | 0.253 | Apoptosis antagonist | 0.219 0.157 DBMET02318 0.253 0.124 DBMET02319 | DBMET02319 | |
| 0.273 | 0.156 | 0.321 | Antibacterial | 0.321 0.12 DBMET02318 0.288 0.145 DBMET02319 | DBMET02318 | |
| 0.155 | 0.041 | 0.155 | Adenylate cyclase inhibitor | 0.101 0.084 DBMET02318 0.129 0.06 DBMET02319 | ||
| 0.168 | 0.057 | 0.168 | Heat shock protein 90 antagonist | |||
| 0.126 | 0.015 | 0.126 | Bile acid receptor antagonist | 0.089 0.077 DBMET02318 0.123 0.017 DBMET02319 | ||
| 0.157 | 0.051 | 0.157 | Adenylate cyclase stimulant | 0.148 0.067 DBMET02319 | ||
| 0.114 | 0.008 | 0.114 | Heat shock protein 90 beta antagonist | |||
| 0.17 | 0.064 | 0.17 | Interleukin 6 antagonist | 0.153 0.085 DBMET02319 | ||
| 0.24 | 0.135 | 0.24 | Transcription factor NF kappa B inhibitor | 0.198 0.171 DBMET02318 | ||
| 0.144 | 0.04 | 0.144 | 5-Lipoxygenase inhibitor | 0.111 0.055 DBMET02319 | ||
| 0.138 | 0.038 | 0.138 | Caspase 3 inhibitor | 0.137 0.039 DBMET02319 | ||
| 0.214 | 0.115 | 0.214 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.206 | 0.108 | 0.206 | Calpain inhibitor | |||
| 0.183 | 0.087 | 0.183 | Amyloid beta aggregation inhibitor | |||
| 0.173 | 0.078 | 0.19 | Lipocortins synthesis antagonist | 0.177 0.073 DBMET02318 0.19 0.063 DBMET02319 | DBMET02319 | |
| 0.115 | 0.027 | 0.182 | GABA A receptor agonist | 0.182 0.012 DBMET02318 | DBMET02318 | |
| 0.218 | 0.132 | 0.218 | Insulysin inhibitor | 0.209 0.143 DBMET02319 | ||
| 0.201 | 0.116 | 0.201 | Superoxide dismutase inhibitor | 0.182 0.139 DBMET02319 | ||
| 0.203 | 0.118 | 0.203 | DNA synthesis inhibitor | 0.185 0.146 DBMET02319 | ||
| 0.275 | 0.191 | 0.291 | Apoptosis agonist | 0.291 0.179 DBMET02318 | DBMET02318 | |
| 0.203 | 0.119 | 0.203 | 5 Hydroxytryptamine release stimulant | |||
| 0.208 | 0.124 | 0.208 | Transcription factor STAT3 inhibitor | |||
| 0.152 | 0.07 | 0.152 | GABA C receptor rho-2 antagonist | |||
| 0.121 | 0.039 | 0.121 | Breast cancer-resistant protein inhibitor | 0.085 0.073 DBMET02319 | ||
| 0.119 | 0.04 | 0.125 | HIV-1 integrase (Overall Integration) inhibitor | 0.125 0.036 DBMET02319 | DBMET02319 | |
| 0.158 | 0.081 | 0.177 | Growth hormone agonist | 0.14 0.095 DBMET02318 0.177 0.069 DBMET02319 | DBMET02319 | |
| 0.152 | 0.077 | 0.152 | Peroxidase inhibitor | 0.124 0.096 DBMET02319 | ||
| 0.16 | 0.085 | 0.16 | Death-associated protein kinase 2 inhibitor | |||
| 0.174 | 0.101 | 0.174 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.152 | 0.079 | 0.152 | Melanin inhibitor | 0.129 0.116 DBMET02318 0.134 0.106 DBMET02319 | ||
| 0.089 | 0.017 | 0.089 | Acetyl-CoA transferase inhibitor | 0.048 0.046 DBMET02318 0.054 0.036 DBMET02319 | ||
| 0.135 | 0.065 | 0.135 | Interleukin 4 antagonist | 0.119 0.087 DBMET02319 | ||
| 0.108 | 0.042 | 0.108 | Protein kinase C zeta inhibitor | |||
| 0.131 | 0.066 | 0.131 | CC chemokine 6 receptor antagonist | 0.123 0.099 DBMET02318 0.123 0.103 DBMET02319 | ||
| 0.214 | 0.15 | 0.214 | Thyroid hormone antagonist | |||
| 0.091 | 0.03 | 0.091 | HIV-1 integrase inhibitor | 0.072 0.046 DBMET02318 0.091 0.03 DBMET02319 | ||
| 0.199 | 0.14 | 0.199 | Transcription factor STAT inhibitor | |||
| 0.184 | 0.126 | 0.184 | RNA-directed DNA polymerase inhibitor | 0.175 0.142 DBMET02318 | ||
| 0.118 | 0.06 | 0.118 | TRPA1 agonist | |||
| 0.153 | 0.095 | 0.153 | LIM domain kinase 1 inhibitor | |||
| 0.134 | 0.08 | 0.134 | Mannose-6-phosphate isomerase inhibitor | |||
| 0.069 | 0.016 | 0.069 | Adenine nucleotide translocase inhibitor | 0.069 0.016 DBMET02319 | ||
| 0.143 | 0.094 | 0.143 | Heat shock protein 90 alpha antagonist | |||
| 0.058 | 0.01 | 0.058 | Retinoic acid alpha receptor agonist | 0.058 0.01 DBMET02318 0.058 0.01 DBMET02319 | ||
| 0.121 | 0.076 | 0.121 | Toll-Like receptor 2 antagonist | 0.112 0.086 DBMET02319 | ||
| 0.167 | 0.125 | 0.167 | Aldehyde oxidase inhibitor | |||
| 0.171 | 0.133 | 0.171 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.195 | 0.158 | 0.195 | Thyroid hormone beta antagonist | |||
| 0.194 | 0.16 | 0.194 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.153 | 0.121 | 0.169 | Angiogenesis stimulant | 0.169 0.111 DBMET02319 | DBMET02319 | |
| 0.073 | 0.041 | 0.073 | Vanilloid 1 antagonist | |||
| 0.12 | 0.089 | 0.12 | Interleukin 1 antagonist | |||
| 0.129 | 0.1 | 0.129 | NOS3 expression enhancer | |||
| 0.188 | 0.16 | 0.188 | MAP kinase kinase 3 inhibitor | |||
| 0.098 | 0.07 | 0.112 | Urease inhibitor | 0.112 0.054 DBMET02318 | DBMET02318 | |
| 0.087 | 0.06 | 0.087 | Interleukin 5 antagonist | |||
| 0.089 | 0.063 | 0.091 | Protein kinase C delta inhibitor | 0.091 0.062 DBMET02318 | DBMET02318 | |
| 0.075 | 0.05 | 0.075 | CDC25A inhibitor | 0.074 0.051 DBMET02319 | ||
| 0.066 | 0.042 | 0.066 | CDC25B inhibitor | 0.062 0.048 DBMET02319 | ||
| 0.121 | 0.098 | 0.181 | Cyclooxygenase inhibitor | 0.181 0.05 DBMET02319 | DBMET02319 | |
| 0.029 | 0.007 | 0.029 | Retinoic acid gamma receptor agonist | 0.023 0.015 DBMET02318 0.029 0.007 DBMET02319 | ||
| 0.034 | 0.013 | 0.034 | Caspase 6 inhibitor | 0.03 0.023 DBMET02318 0.034 0.014 DBMET02319 | ||
| 0.116 | 0.096 | 0.116 | Histone deacetylase SIRT1 inhibitor | |||
| 0.041 | 0.023 | 0.059 | MAP3K5 inhibitor | 0.059 0.006 DBMET02318 0.049 0.013 DBMET02319 | DBMET02318 | |
| 0.098 | 0.08 | 0.098 | Protein kinase C gamma inhibitor | |||
| 0.049 | 0.032 | 0.049 | Mineralocorticoid receptor antagonist | |||
| 0.13 | 0.113 | 0.13 | Arachidonic acid antagonist | 0.128 0.115 DBMET02319 | ||
| 0.101 | 0.086 | 0.101 | Photosensitizer | 0.099 0.091 DBMET02319 | ||
| 0.097 | 0.083 | 0.102 | GABA C receptor antagonist | 0.102 0.075 DBMET02318 | DBMET02318 | |
| 0.028 | 0.015 | 0.03 | Thyroid hormone agonist | 0.03 0.012 DBMET02319 | DBMET02319 | |
| 0.029 | 0.017 | 0.029 | Motilin receptor antagonist | |||
| 0.025 | 0.013 | 0.025 | Retinoic acid receptor agonist | 0.025 0.014 DBMET02319 | ||
| 0.014 | 0.005 | 0.014 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | 0.013 0.008 DBMET02318 0.012 0.008 DBMET02319 | ||
| 0.122 | 0.114 | 0.154 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.154 0.086 DBMET02318 | DBMET02318 | |
| 0.218 | 0.211 | 0.218 | DNA polymerase beta inhibitor | |||
| 0.079 | 0.073 | 0.079 | D-Ala-D-Ala ligase inhibitor | |||
| 0.108 | 0.103 | 0.108 | Cytokine production inhibitor | |||
| 0.019 | 0.015 | 0.02 | Retinoic acid beta receptor agonist | 0.02 0.014 DBMET02319 | DBMET02319 | |
| 0.111 | 0.109 | 0.111 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.154 | 0.153 | 0.154 | Tumour necrosis factor alpha release inhibitor | |||
| 0.06 | 0.063 | 0.066 | Histidine decarboxylase inhibitor | 0.066 0.055 DBMET02319 | DBMET02319 | |
| 0.105 | 0.109 | 0.112 | Protein kinase (CK1) gamma inhibitor | 0.112 0.099 DBMET02318 | DBMET02318 | |
| 0.12 | 0.128 | 0.127 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.127 0.118 DBMET02318 | DBMET02318 | |
| 0.058 | 0.068 | 0.071 | Prostaglandin-E synthase inhibitor | 0.071 0.047 DBMET02318 0.062 0.06 DBMET02319 | DBMET02318 | |
| 0.053 | 0.067 | 0.072 | Leukotriene synthesis inhibitor | 0.072 0.042 DBMET02318 | DBMET02318 | |
| 0.128 | 0.147 | 0.167 | ATPase inhibitor | 0.167 0.074 DBMET02318 | DBMET02318 | |
| 0.124 | 0.145 | 0.147 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.147 0.123 DBMET02318 | DBMET02318 | |
| 0.084 | 0.109 | 0.094 | Protein kinase (CK1) gamma 2 inhibitor | 0.094 0.092 DBMET02318 | DBMET02318 | |
| 0.117 | 0.15 | 0.133 | Tumour necrosis factor antagonist | 0.133 0.122 DBMET02318 | DBMET02318 | |
| 0.165 | 0.202 | 0.209 | Cholesterol antagonist | 0.209 0.157 DBMET02318 | DBMET02318 | |
| 0.026 | 0.064 | 0.059 | Phosphorylase inhibitor | 0.059 0.025 DBMET02319 | DBMET02319 | |
| 0.045 | 0.101 | 0.055 | Leukotriene C antagonist | 0.055 0.043 DBMET02318 | DBMET02318 | |
| 0.075 | 0.147 | 0.117 | Cyclooxygenase 2 inhibitor | 0.117 0.082 DBMET02319 | DBMET02319 | |
| 0.051 | 0.126 | 0.075 | Peroxisome proliferator-activated receptor gamma antagonist | 0.075 0.042 DBMET02319 | DBMET02319 | |
| 0.066 | 0.143 | 0.097 | DNA polymerase I inhibitor | 0.097 0.089 DBMET02318 | DBMET02318 | |
| 0.083 | 0.175 | 0.276 | Interleukin 2 antagonist | 0.276 0.005 DBMET02319 | DBMET02319 | |
| 0.07 | 0.164 | 0.164 | Hedgehog signaling inhibitor | 0.164 0.019 DBMET02318 | DBMET02318 | |
| 0.109 | 0.203 | 0.164 | Antiamyloidogenic | 0.164 0.129 DBMET02319 | DBMET02319 | |
| 0.06 | 0.157 | 0.099 | ABCA1 expression enhancer | 0.099 0.051 DBMET02319 | DBMET02319 | |
| 0.075 | 0.199 | 0.139 | Protein-tyrosine phosphatase inhibitor | 0.139 0.091 DBMET02318 | DBMET02318 | |
| 0.013 | 0.141 | 0.049 | Cannabinoid CB2 receptor antagonist | 0.049 0.037 DBMET02318 | DBMET02318 | |
| 0.054 | 0.213 | 0.119 | Bone formation stimulant | 0.119 0.087 DBMET02318 | DBMET02318 | |
| 0.012 | 0.191 | 0.034 | Peroxisome proliferator-activated receptor delta antagonist | 0.034 0.022 DBMET02319 | DBMET02319 | |
| 0.051 | 0.277 | 0.085 | Hematopoietic | 0.085 0.061 DBMET02318 | DBMET02318 | |
| 0.115 | 0.348 | 0.368 | Toll-Like receptor 7 agonist | 0.368 0.073 DBMET02319 | DBMET02319 | |
| 0.006 | 0.239 | 0.024 | Leukotriene B4 receptor 2 antagonist | 0.024 0.013 DBMET02319 | DBMET02319 | |
| 0.01 | 0.253 | 0.042 | Granulocyte colony stimulating factor receptor agonist | 0.042 0.002 DBMET02318 | DBMET02318 | |
| 0.111 | 0.357 | 0.363 | Toll-Like receptor agonist | 0.363 0.076 DBMET02319 | DBMET02319 | |
| 0.054 | 0.35 | 0.152 | Platelet antagonist | 0.152 0.143 DBMET02319 | DBMET02319 | |
| 0.069 | 0.406 | 0.23 | Immunosuppressant | 0.23 0.166 DBMET02319 | DBMET02319 | |
| 0.007 | 0.377 | 0.027 | Liver X receptor alpha antagonist | 0.027 0.025 DBMET02318 | DBMET02318 | |
| 0.024 | 0.57 | 0.207 | Amyloid beta precursor protein antagonist | 0.207 0.053 DBMET02319 | DBMET02319 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |